Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01082900 · ClinicalTrials.gov registry record · NA
Prophylactic Continuous Positive Airway Pressure (CPAP) in Delivery Room, in the Prevention of Transient Tachypnea of Newborn (TTN): A Randomized Controlled Trial
A NA study of Transient Tachypnea, sponsored by New York Hospital Queens.
- Completed
- Registry status
- NA
- Development phase
- 138
- Enrollment target
- 1
- Study location
NCT01082900: Completed NA study of Transient Tachypnea, sponsored by New York Hospital Queens.
NCT01082900 is a NA study of Transient Tachypnea that has completed, run by New York Hospital Queens. The registered enrollment target is 138 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01082900, a NA study of Transient Tachypnea, has completed, sponsored by New York Hospital Queens.
- COMPLETED
- Registry status
- NA
- Development phase
- 138 participants
- Enrollment target
- 1
- Study location
Study Summary
Transient Tachypnea of the Newborn (TTN) is a disorder of delayed clearance of lung liquid and a common cause of admission of full term infants and late pre term infants (34 to 36 weeks) to Neonatal Intensive Care Units (NICU). Both late preterm gestational age at delivery, and mode of delivery are considered risk factors for TTN. The investigators hypothesize that CPAP administered prophylactically in the Delivery Room via a T piece based infant resuscitator Neopuff, to neonates at increased risk for TTN, would decrease the incidence of TTN and thus decrease the need for hospitalization in the NICU. This is a pilot study to evaluate the prophylactic administration of CPAP in the Delivery Room towards prevention of TTN and it's effects on natriuretic peptides.The study will be conducted as a randomized control trial after obtaining informed consents from the parents of eligible infants. Infants will be randomized to receive either experimental treatment (prophylactic CPAP) or standardized care.
Conditions Studied
Interventions
- OTHER Prophylactic CPAP Administration
Study Locations (1)
New York
- New York Hospital Queens - Flushing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2009-11 |
| Est. Completion | 2013-04 |
| Phase | NA |
What the finished NCT01082900 record still lists
NCT01082900 is an interventional study that assigns participants to a tested intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Transient Tachypnea appearing as the primary indexed condition, and to 1 intervention - of which Prophylactic CPAP Administration is the first listed.
NCT01082900 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01082900 about?
NCT01082900 is a clinical study titled "Prophylactic Continuous Positive Airway Pressure (CPAP) in Delivery Room, in the Prevention of Transient Tachypnea of Newborn (TTN): A Randomized Controlled Trial". Transient Tachypnea of the Newborn (TTN) is a disorder of delayed clearance of lung liquid and a common cause of admission of full term infants and late pre term infants (34 to 36 weeks) to Neonatal Intensive Care Units (NICU). Both late preterm gestational age at delivery, and mode of delivery are ...
What is the current status of trial NCT01082900?
This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2009-11. Estimated completion is 2013-04.
What conditions does trial NCT01082900 study?
This clinical trial studies the following conditions: Transient Tachypnea.
What interventions are being tested in trial NCT01082900?
The interventions under investigation include: Prophylactic CPAP Administration (OTHER).
Who is sponsoring clinical trial NCT01082900?
This trial is sponsored by New York Hospital Queens, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01082900 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01082900's enrollment target sits among peer trials
138 720th of 2000 higher than 1,279 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04402788 · 138 participants · Phase 2
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- NCT04883255 · 138 participants · Early Phase 1
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
- NCT05620784 · 138 participants · Phase 3
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
- NCT05832086 · 138 participants · Phase 2
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia